Korro Bio (KRRO) Current Assets (2018 - 2026)

Korro Bio (KRRO) has reported Current Assets for 9 consecutive years, with $120.6 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Current Assets rose 17.54% year-over-year to $120.6 million; the trailing twelve-month figure through Jun 2026 stood at $120.6 million (up 17.54% YoY), and the FY2025 full-year result was $82.4 million, down 37.37% from the prior year.
• Current Assets was little changed at $120.6 million in Q2 2026 per KRRO's latest filing, from $120.2 million in the prior quarter.
• Across five years, Current Assets topped out at $172.7 million in Q4 2023 and bottomed at $42.5 million in Q3 2023.
• Historically, Current Assets has averaged $109.1 million across 5 years, with a median of $116.7 million in 2022.
• The sharpest annual moves came in 2023 and 2024: Current Assets plunged 57.92% in 2023, then jumped 259.49% in 2024.
• Over 5 years, Current Assets stood at $57.1 million in 2022, then soared by 202.59% to $172.7 million in 2023, then dropped by 23.85% to $131.5 million in 2024, then slumped by 37.37% to $82.4 million in 2025, then jumped by 46.45% to $120.6 million in 2026.
• According to Business Quant data, Current Assets over the past three periods registered $120.6 million, $120.2 million, and $82.4 million for Q2 2026, Q1 2026, and Q4 2025 respectively.